Roivant Sciences ROIV
NASDAQ ROIV
$35.72 +0.22 (+0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Other Accumulated Expenses (2021 - 2026)

Updated

Roivant Sciences (ROIV) posted Other Accumulated Expenses of $3.21 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 93.5% from $49.8 million a year earlier but up 451.1% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Other Accumulated Expenses came in at $583,000, down 50.1% from FY2025.

  • Annual Other Accumulated Expenses has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -29.1% (FY2021 to FY2026).
  • In prior fiscal years, Roivant Sciences' Other Accumulated Expenses was $1.17 million in FY2025 (-96.9%), $37.71 million in FY2024 (-50.6%), $76.28 million in FY2023 (+15.2%) and $66.19 million in FY2022.
  • Quarterly Other Accumulated Expenses has run from a low of $583,000 in fiscal Q4 2026 to a high of $76.28 million in fiscal Q4 2023 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has declined in each of the last four quarters, with an average decline of 51.4% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was fiscal Q2 2023, with growth of 527.9%; the weakest was fiscal Q2 2026, with a decline of 97.4%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior fiscal quarters was $583,000 (Q4 2026), $10.24 million (Q3 2026) and $1.48 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Roivant Sciences 25.81 Bn 26.50 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.21 Mn
Mar 31, 2026 583,000.00
Dec 31, 2025 10.24 Mn
Sep 30, 2025 1.48 Mn
Jun 30, 2025 49.80 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 53.47 Mn
Sep 30, 2024 56.30 Mn
Jun 30, 2024 46.46 Mn
Mar 31, 2024 37.71 Mn
Dec 31, 2023 43.63 Mn
Sep 30, 2023 72.55 Mn
Jun 30, 2023 57.16 Mn
Mar 31, 2023 76.28 Mn
Dec 31, 2022 56.33 Mn
Sep 30, 2022 66.92 Mn
Jun 30, 2022 4.08 Mn
Mar 31, 2022 66.19 Mn
Dec 31, 2021 12.44 Mn
Sep 30, 2021 10.66 Mn
API Access

Roivant Sciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ROIV&period=max&api_key=YOUR_API_KEY